GILD vs. BMY
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or BMY.
Correlation
The correlation between GILD and BMY is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GILD vs. BMY - Performance Comparison
Key characteristics
GILD:
2.39
BMY:
0.08
GILD:
3.36
BMY:
0.36
GILD:
1.43
BMY:
1.04
GILD:
2.01
BMY:
0.05
GILD:
13.25
BMY:
0.29
GILD:
4.51%
BMY:
8.83%
GILD:
25.08%
BMY:
31.08%
GILD:
-70.82%
BMY:
-70.62%
GILD:
-11.51%
BMY:
-34.35%
Fundamentals
GILD:
$132.33B
BMY:
$99.09B
GILD:
$4.76
BMY:
$2.68
GILD:
21.67
BMY:
17.87
GILD:
0.22
BMY:
2.26
GILD:
4.61
BMY:
2.08
GILD:
6.73
BMY:
5.61
GILD:
$22.06B
BMY:
$47.64B
GILD:
$17.36B
BMY:
$34.47B
GILD:
$7.98B
BMY:
$11.69B
Returns By Period
In the year-to-date period, GILD achieves a 12.48% return, which is significantly higher than BMY's -13.45% return. Over the past 10 years, GILD has outperformed BMY with an annualized return of 3.78%, while BMY has yielded a comparatively lower 0.36% annualized return.
GILD
12.48%
-7.71%
17.72%
63.62%
9.96%
3.78%
BMY
-13.45%
-19.33%
-5.71%
12.05%
-1.54%
0.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. BMY — Risk-Adjusted Performance Rank
GILD
BMY
GILD vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GILD vs. BMY - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 3.00%, less than BMY's 5.09% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 3.00% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% |
BMY Bristol-Myers Squibb Company | 5.09% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
GILD vs. BMY - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for GILD and BMY. For additional features, visit the drawdowns tool.
Volatility
GILD vs. BMY - Volatility Comparison
The current volatility for Gilead Sciences, Inc. (GILD) is 8.79%, while Bristol-Myers Squibb Company (BMY) has a volatility of 9.92%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GILD vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities